Loading organizations...
Loading organizations...
Biotech company developing therapies for neuromuscular diseases.
NMD Pharma has raised $121.0M across 2 funding rounds.
NMD Pharma has raised $121.0M in total across 2 funding rounds.
NMD Pharma has raised $121.0M in total across 2 funding rounds.
NMD Pharma's investors include Sabine Dandiguian, INKEF Capital, Lundbeckfonden BioCapital, Novo Holdings, Roche, Roel Bulthuis, Lundbeckfonden.
NMD Pharma has raised $121.0M across 2 funding rounds. Most recently, it raised $81.4M Series B in November 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 16, 2023 | $81.4M Series B | Sabine Dandiguian | INKEF Capital, Lundbeckfonden BioCapital, Novo Holdings, Roche |
| Feb 15, 2022 | $39.6M Other Equity | Sabine Dandiguian | Roel Bulthuis, Lundbeckfonden, Novo Holdings, Roche |